Table 2

Characteristics of Peutz-Jeghers syndrome patients with pancreatic cancer (A) and with distal bile duct cancer and ampullary cancer (B)

Germline LKB1 mutation in patient (germline LKB1 mutation in family)Age at diagnosis (year of diagnosis)Age at deathType of cancerConfirmationLocation tumourDistant metastasesOther malignancy in medical history (year of diagnosis)
(A)
1.+ (+)*35 (1998)35AdenocarcinomaHIHeadYesNo
2.NT (c.370A>T, p.Lys124X)57 (1994)†58AdenocarcinomaHIHeadYesUnknown
3.NT (c.468C>G, p.Tyr156X)66 (1998)68AdenocarcinomaHIHeadYesColon cancer pT2NxMx (1996)
4.c.991dupC, p.Arg331fs36 (1997)36AdenocarcinomaHIHeadYesNo
5.c.582C>A, p.Asp194Glu45 (2008)46Acinar cell carcinomaHITailYesLiposarcoma (1992)
6.Deletion exon 6, 7 and 854 (2004)54AdenocarcinomaMRHeadYesNo
7.− (−)62 (2005)62AdenocarcinomaHIHeadYesNo
(B)
1.c.156_157dupGG, p.Asp53fs57 (2006)57Bile duct cancerHIDistal bile ductYesNo
2.NT (unknown)73 (2008)74Bile duct cancerHIDistal bile ductYesNo
3.c.291-2A>G, p.98_155del53 (2006)58Ampullary NETHIAmpullaYesNon-Hodgkin lymphoma grade 3 (2001)
4.c.735-1G>A, p.?41 (2000)Dysplastic hamartoma near the ampulla with invasive growth in the ampullaHIAmpullaNoNo
  • *Specific LKB1 germline mutation unknown.

  • †Occurred in retrospective follow-up period.

  • F, female; HI, histology; M, male; MR, medical record; NET, neuroendocrine tumour; NT, not tested; +, proven germline LKB1 mutation; −, tested but no germline mutation detected.